Alloy vs Hims & Hers
Vial Take
Both platforms clear the federal compliance bar (FDA, OIG, DEA, HIPAA) and land in Vial's top quartile, so you're not choosing between a safe option and a risky one. The bigger gap is credentialing transparency flipped against pharmacy transparency: Alloy tells you exactly who the physicians are, board-certified OB/GYNs specializing in menopause, but won't name its pharmacy partners, while Hims & Hers discloses its pharmacy operation and holds LegitScript certification (a bar only 5% of platforms clear) but gives you nothing on physician credentials. If specialist pedigree matters most to you, Alloy's clinical transparency is the edge; if pharmacy accountability and national reach are your priority, Hims & Hers's 13-point trust score advantage and LegitScript status carry real weight.
Biggest Differences
- Pharmacy disclosureHims & Hers publishes its compounding partner (Hims & Hers), so you can verify the supply chain; Alloy does not name a pharmacy partner publicly.
- LegitScript certificationHims & Hers holds LegitScript certification (the credential required to advertise on Google and Meta); Alloy does not.
- Trust Score gap (13 points)Hims & Hers scores 88/100 to Alloy's 75/100, a 13-point spread driven by the differences below.
Alloy
Telehealth PlatformHims & Hers
Telehealth PlatformWant to run a full compliance report on either provider?
Related
Other comparisons featuring these providers
Comparison based on public federal and state records including NPI Registry, FDA enforcement database, and PCAB accreditation directory. Updated weekly. Not a medical endorsement.